A Q&A article published by Pharmaceutical Market Europe (PME) featuring Chris Learn and Martin Lachs, discussing how best to achieve success in an increasingly crowded and competitive immuno-oncology field, where the rapid evolution of trial design has occurred as a competitive necessity.
Download Article